Collegium Pharmaceutical, Inc.
COLL
$47.85
$0.340.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.36% | 5.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.36% | 5.76% | |||
| Cost of Revenue | -2.39% | 3.29% | |||
| Gross Profit | 13.20% | 6.10% | |||
| SG&A Expenses | -9.84% | -4.87% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.11% | -1.97% | |||
| Operating Income | 77.17% | 54.39% | |||
| Income Before Tax | 155.13% | 445.32% | |||
| Income Tax Expenses | 136.59% | 615.18% | |||
| Earnings from Continuing Operations | 162.93% | 395.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 162.93% | 395.78% | |||
| EBIT | 77.17% | 54.39% | |||
| EBITDA | 30.71% | 16.43% | |||
| EPS Basic | 164.93% | 395.66% | |||
| Normalized Basic EPS | 147.48% | 236.13% | |||
| EPS Diluted | 143.33% | 392.29% | |||
| Normalized Diluted EPS | 143.32% | 182.82% | |||
| Average Basic Shares Outstanding | -0.75% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.93% | 18.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||